MPC vs RNAC · P/E 16, rev $138.86B vs P/E 2.1, rev $38.9M
Marathon Petroleum Corp (MPC) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the MPC and RNAC stock pages for the full models.
Not investment advice.